NASDAQ:EVFM

Evofem Biosciences Stock News

etoro logo Buy EVFM
*Your capital is at risk
$0.0080
+0.0015 (+23.08%)
At Close: Jun 03, 2026
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech Stocks Hitting 52-week Highs May 5) • Adverum Biotechnologies...
April turned out to be a productive month in terms of drug approvals, with the FDA issuing positive verdicts on almost all applications for which decisions were due. The month saw...
Evofem Biosciences, Inc. (NASDAQ: EVFM), a clinical-stage biopharmaceutical company, today announced that the location of its annual general meeting scheduled for May 12, 2020 at 8:00 am PDT has been
ATLANTA (AP) — Dan Quinn says the NFC South has earned a new moniker. The Atlanta Falcons coach notes the division “is turning into Quarterback South.” Tom Brady's arrival has raised...
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Evofem Biosciences (EVFM) today and set a price target of $11.00. The company's shares
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Evofem Biosciences (EVFM – Research Report) today and set a

Yelich: 50-50 chance MLB is played in 2020

05:02am, Wednesday, 08'th Apr 2020
While Major League Baseball and the players union are exploring various avenues for starting the delayed season, at least one superstar isn't convinced the season will be held at all.
NEW YORK, NY / ACCESSWIRE / April 6, 2020 / Solebury Trout, a boutique investor relations and corporate communications firm, announced today that it will be hosting a fourth day of presentations as pa
RBC Capital analyst Randall Stanicky maintained a Buy rating on Evofem Biosciences (EVFM) today and set a price target of $6.00. The company's shares
RBC Capital analyst Randall Stanicky maintained a Buy rating on Evofem Biosciences ( EVFM – Research Report ) today and set a price target of $6.00 . The company’s shares closed last Monday at $4.
When Tom Brady signed with the Tampa Bay Buccaneers, the world knew there must be more to the story.
Tom Brady’s departure from the New England Patriots brings an end to one of the NFL’s most memorable eras. It also means fans should prepare for the sight of Brady in another...
For two decades, Tom Brady was the face of the Patriots, and even of the NFL. When he turns 43 in August, his home address no longer will be in New England. The six-time Super Bowl champion...
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Evofem Biosciences (EVFM) today and set a price target of $11.00. The company's shares

Lisa Ellis

10:00am, Friday, 13'th Mar 2020
Lisa Ellis is a partner and senior equity analyst at MoffettNathanson.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE